- Home
- IMPP vs ALEC Comparison
IMPP vs ALEC Comparison
Compare IMPP & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMPP | ALEC |
|---|---|---|
| Founded | 1981 | 2013 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 137.7M | 133.2M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | IMPP | ALEC |
|---|---|---|
| Price | $3.79 | $1.79 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 7 |
| Target Price | ★ $5.50 | $3.33 |
| AVG Volume (30 Days) | 723.4K | ★ 1.4M |
| Earning Date | 02-12-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.03 | N/A |
| Revenue | ★ $136,071,654.00 | $69,048,000.00 |
| Revenue This Year | $7.55 | N/A |
| Revenue Next Year | $58.58 | $155.87 |
| P/E Ratio | $3.63 | ★ N/A |
| Revenue Growth | N/A | ★ 12.26 |
| 52 Week Low | $2.12 | $0.87 |
| 52 Week High | $6.57 | $3.40 |
Technical Indicators
Market Signals| Indicator | IMPP | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 37.73 | 70.19 |
| Support Level | $3.63 | $1.50 |
| Resistance Level | $3.88 | $1.62 |
| Average True Range (ATR) | 0.16 | 0.09 |
| MACD | 0.05 | 0.05 |
| Stochastic Oscillator | 56.86 | 98.88 |
Price Performance
Historical ComparisonAbout IMPP Imperial Petroleum Inc.
Imperial Petroleum Inc is a provider of international seaborne transportation services to oil producers, refineries, and commodities traders. It owns and operates a fleet of six medium-range product tankers that carry refined petroleum products such as gasoline, diesel, fuel oil, and jet fuel, as well as edible oils and chemicals.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.